Daré Bioscience’s DARE-LARC1 Platform Technology has Transformative Potential for Women’s Health as well as in Treating a ...

part of Bausch Health Companies Inc. (NYSE/TSX:BHC), today announced that PrCABTREOTM (clindamycin phosphate, adapalene and benzoyl peroxide) gel 1.2% w/w, 0.15% w/w and 3.1% ... ACCESSWIRE • 14 ...

Seralutinib becomes XOMA Royalty's seventh Phase 3 royalty asset, further building the late-stage pipeline beyond its six ...

Topical antibiotics available for treating acne include clindamycin (1% gel, lotion ... must have hematologic monitoring. A glucose-6-phosphate dehydrogenase level must be normal before beginning ...

THE selective inhibition of radiostrontium uptake by rats following the administration of doses of sodium alginate has been reported recently 1–3. We have performed a similar experiment with a ...